0001478242-20-000059.txt : 20200811
0001478242-20-000059.hdr.sgml : 20200811
20200811170220
ACCESSION NUMBER: 0001478242-20-000059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200807
FILED AS OF DATE: 20200811
DATE AS OF CHANGE: 20200811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAUB W RICHARD
CENTRAL INDEX KEY: 0001181162
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35907
FILM NUMBER: 201093186
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IQVIA HOLDINGS INC.
CENTRAL INDEX KEY: 0001478242
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 271341991
STATE OF INCORPORATION: NC
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4820 EMPEROR BLVD.
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-998-2000
MAIL ADDRESS:
STREET 1: 4820 EMPEROR BLVD.
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc.
DATE OF NAME CHANGE: 20161003
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc.
DATE OF NAME CHANGE: 20091208
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-08-07
0001478242
IQVIA HOLDINGS INC.
IQV
0001181162
STAUB W RICHARD
C/O IQVIA HOLDINGS INC.
4820 EMPEROR BLVD.
DURHAM
NC
27703
0
1
0
0
See Remarks
Common Stock
2020-08-07
4
M
0
7508
53.26
A
19978
D
Common Stock
2020-08-07
4
M
0
2475
64.93
A
22453
D
Common Stock
2020-08-07
4
M
0
3500
64.67
A
25953
D
Common Stock
2020-08-07
4
S
0
13483
160.47
D
12470
D
Common Stock
2020-08-07
4
M
0
14262
95.23
A
26732
D
Common Stock
2020-08-07
4
M
0
6145
131.82
A
32877
D
Common Stock
2020-08-07
4
S
0
6884
160.04
D
25993
D
Common Stock
2020-08-07
4
D
0
13523
160.54
D
12470
D
Employee Stock Option (Right to Buy)
53.26
2020-08-07
4
M
0
7508.0
0.0
D
2018-02-25
2024-02-25
Common Stock
7508.0
0
D
Employee Stock Option (Right to Buy)
64.93
2020-08-07
4
M
0
2475
0.0
D
2019-03-04
2025-03-04
Common Stock
2475
0
D
Employee Stock Option (Right to Buy)
64.67
2020-08-07
4
M
0
3500
0.0
D
2020-03-03
2026-03-03
Common Stock
3500
0
D
Stock Appreciation Right
95.23
2020-08-07
4
M
0
14262
0.0
D
2020-02-08
2028-02-08
Common Stock
14262
7132
D
Stock Appreciation Right
131.82
2020-08-07
4
M
0
6145
0.0
D
2020-02-13
2029-02-13
Common Stock
6145
12291
D
The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $160.00 to $160.81 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $160.00 to $160.15 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
President, Research & Development Solutions
/s/ Matthew Gilmartin, Attorney-in-Fact for W. Richard Staub
2020-08-11